210 related articles for article (PubMed ID: 23208483)
21. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of occult hepatitis B in HIV infected patients].
Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients.
Maylin S; Boyd A; Lavocat F; Gozlan J; Lascoux-Combe C; Miailhes P; Lassel L; Delaugerre C; Girard PM; Zoulim F; Lacombe K
AIDS; 2012 May; 26(8):939-49. PubMed ID: 22333748
[TBL] [Abstract][Full Text] [Related]
24. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V
J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759
[TBL] [Abstract][Full Text] [Related]
25. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
26. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.
Malagnino V; Cerva C; Maffongelli G; Teti E; Foroghi Biland L; Cesta N; De Masi M; Stingone C; Armenia D; Svicher V; Salpini R; Andreoni M; Sarmati L
Sci Rep; 2019 Aug; 9(1):11942. PubMed ID: 31420570
[TBL] [Abstract][Full Text] [Related]
27. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J;
J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028
[TBL] [Abstract][Full Text] [Related]
28. A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.
lsa SE; Gwamzhi LN; Akolo C; Giyan J
Niger J Med; 2010; 19(3):279-85. PubMed ID: 20845631
[TBL] [Abstract][Full Text] [Related]
29. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
Wang H; Li Y; Zhang C; Han Y; Zhang X; Zhu T; Li T
AIDS; 2012 Sep; 26(14):1755-63. PubMed ID: 22614885
[TBL] [Abstract][Full Text] [Related]
30. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
31. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
33. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
[TBL] [Abstract][Full Text] [Related]
34. Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
Clotet B; Clumeck N; Katlama C; Nijs S; Witek J
J Antimicrob Chemother; 2010 Nov; 65(11):2450-4. PubMed ID: 20801782
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
Petoumenos K; Ringland C;
HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
37. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
[TBL] [Abstract][Full Text] [Related]
38. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients.
Hønge B; Jespersen S; Medina C; Té D; da Silva Z; Ostergaard L; Laursen A; Wejse C; Krarup H; Erikstrup C;
HIV Med; 2014 Oct; 15(9):571-6. PubMed ID: 24717010
[TBL] [Abstract][Full Text] [Related]
40. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P;
Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]